Free Trial
NYSE:CNMD

CONMED (CNMD) Stock Price, News & Analysis

CONMED logo
$54.04 +1.96 (+3.77%)
Closing price 03:59 PM Eastern
Extended Trading
$54.06 +0.02 (+0.04%)
As of 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About CONMED Stock (NYSE:CNMD)

Key Stats

Today's Range
$51.92
$55.19
50-Day Range
$48.91
$60.75
52-Week Range
$46.00
$78.19
Volume
412,370 shs
Average Volume
445,213 shs
Market Capitalization
$1.67 billion
P/E Ratio
14.22
Dividend Yield
1.48%
Price Target
$62.20
Consensus Rating
Hold

Company Overview

CONMED Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
92nd Percentile Overall Score

CNMD MarketRank™: 

CONMED scored higher than 92% of companies evaluated by MarketBeat, and ranked 88th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CONMED has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 1 buy rating, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    CONMED has only been the subject of 4 research reports in the past 90 days.

  • Read more about CONMED's stock forecast and price target.
  • Earnings Growth

    Earnings for CONMED are expected to grow by 16.55% in the coming year, from $4.35 to $5.07 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CONMED is 14.22, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.87.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CONMED is 14.22, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.22.

  • Price to Earnings Growth Ratio

    CONMED has a PEG Ratio of 1.34. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    CONMED has a P/B Ratio of 1.73. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about CONMED's valuation and earnings.
  • Percentage of Shares Shorted

    7.94% of the float of CONMED has been sold short.
  • Short Interest Ratio / Days to Cover

    CONMED has a short interest ratio ("days to cover") of 5.3.
  • Change versus previous month

    Short interest in CONMED has recently decreased by 8.81%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    CONMED pays a meaningful dividend of 1.54%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    CONMED does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of CONMED is 21.05%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, CONMED will have a dividend payout ratio of 15.78% next year. This indicates that CONMED will be able to sustain or increase its dividend.

  • Read more about CONMED's dividend.
  • Percentage of Shares Shorted

    7.94% of the float of CONMED has been sold short.
  • Short Interest Ratio / Days to Cover

    CONMED has a short interest ratio ("days to cover") of 5.3.
  • Change versus previous month

    Short interest in CONMED has recently decreased by 8.81%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    CONMED has a news sentiment score of 0.97. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for CONMED this week, compared to 5 articles on an average week.
  • Search Interest

    4 people have searched for CNMD on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CONMED insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $227,760.00 in company stock.

  • Percentage Held by Insiders

    Only 3.10% of the stock of CONMED is held by insiders.

  • Read more about CONMED's insider trading history.
Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

CNMD Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
1 Profitable Stock Worth Investigating and 2 to Avoid
Needham Downgrades CONMED (CNMD) Stock
See More Headlines

CNMD Stock Analysis - Frequently Asked Questions

CONMED's stock was trading at $68.44 at the start of the year. Since then, CNMD shares have decreased by 21.0% and is now trading at $54.0430.
View the best growth stocks for 2025 here
.

CONMED Corporation (NYSE:CNMD) posted its quarterly earnings data on Wednesday, April, 30th. The company reported $0.95 EPS for the quarter, beating analysts' consensus estimates of $0.81 by $0.14. CONMED's quarterly revenue was up 2.9% on a year-over-year basis.
Read the conference call transcript
.

CONMED's top institutional shareholders include Confluence Investment Management LLC (0.42%). Insiders that own company stock include Charles Farkas, Daniel S Jonas, Pat Beyer, Brian Concannon, Curt R Hartman, Martha Goldberg Aronson, Peter K Shagory, Barbara J Schwarzentraub, Johonna Marie Pelletier, John D Ferrell, Stanley W Peters III, Todd W Garner and Richard Glaze.
View institutional ownership trends
.

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CONMED investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

Record date for 4/4 Dividend
3/14/2025
Ex-Dividend for 4/4 Dividend
3/14/2025
Dividend Payable
4/04/2025
Last Earnings
4/30/2025
Record date for 7/3 Dividend
6/13/2025
Ex-Dividend for 7/3 Dividend
6/13/2025
Today
7/01/2025
Dividend Payable
7/03/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Medical Equipment
Current Symbol
NYSE:CNMD
Employees
3,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$62.20
High Stock Price Target
$80.00
Low Stock Price Target
$55.00
Potential Upside/Downside
+14.7%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
14.24
Forward P/E Ratio
12.46
P/E Growth
1.34
Net Income
$132.42 million
Pretax Margin
11.04%

Debt

Sales & Book Value

Annual Sales
$1.31 billion
Cash Flow
$6.98 per share
Price / Cash Flow
7.77
Book Value
$31.16 per share
Price / Book
1.74

Miscellaneous

Free Float
29,981,000
Market Cap
$1.68 billion
Optionable
Optionable
Beta
1.24
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NYSE:CNMD) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners